{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:33:56Z","timestamp":1792802036183,"version":"4.5.0"},"reference-count":35,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"European Foundation for the Study of Diabetes Future Leader Award","award":["NNF21SA0072746"],"award-info":[{"award-number":["NNF21SA0072746"]}],"id":[{"id":"https:\/\/ror.org\/05tgz4m05","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["1052-00003B"],"award-info":[{"award-number":["1052-00003B"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["10.46540\/4308-00056B"],"award-info":[{"award-number":["10.46540\/4308-00056B"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["10.46540\/4285-00131B"],"award-info":[{"award-number":["10.46540\/4285-00131B"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordic Foundation","doi-asserted-by":"publisher","award":["NNF23OC0084970"],"award-info":[{"award-number":["NNF23OC0084970"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordic Foundation","doi-asserted-by":"publisher","award":["NNF19OC0055001"],"award-info":[{"award-number":["NNF19OC0055001"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordic Foundation","doi-asserted-by":"publisher","award":["NNF24OC0088402"],"award-info":[{"award-number":["NNF24OC0088402"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Follistatin inhibits TGF-\u03b2 superfamily ligands, is involved in muscle atrophy, and is elevated in several endocrine disorders and in response to exercise or fasting. Follistatin is expressed in various tissues, with the liver as a major contributor to the circulating levels. Current evidence shows contradictory results on whether circulating levels of follistatin displays a circadian rhythm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterize the 24-hour temporal pattern of plasma follistatin in healthy young men.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Observational 24-hour study with blood sampling every three hours. Cosinor rhythmometry and 1-way repeated measures ANOVA were used to analyze plasma follistatin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Controlled research facility simulating normal daily life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients or Other Participants<\/jats:title>\n                    <jats:p>Twenty-two healthy young men were included in this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention(s)<\/jats:title>\n                    <jats:p>No interventions were applied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measure(s)<\/jats:title>\n                    <jats:p>Plasma concentrations of follistatin. This was measured to investigate the temporal pattern of follistatin to gain insight into its physiological actions and regulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Plasma follistatin showed a significant 24-hour rhythm (P &amp;lt; .001) with a relative amplitude of 18% around a rhythm adjusted average (mesor \u00b1 SD) of 873 \u00b1 25 pg\/mL, peaking at 11:50 Am. ANOVA confirmed a significant effect of time, with morning and evening levels differing significantly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Plasma follistatin displayed a significant 24-hour rhythm in our cohort of 22 healthy young men. Although meal intake, particularly protein, influences follistatin, it does not fully explain the observed rhythm. Further studies are needed to confirm this rhythm and clarify its clinical relevance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag121","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:48:36Z","timestamp":1773838116000},"page":"e2154-e2160","source":"Crossref","is-referenced-by-count":2,"title":["Circulating plasma follistatin follows a 24-hour rhythm in healthy young males"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3592-5222","authenticated-orcid":false,"given":"Dorte Bonde","family":"Zilstorff","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital , 2400 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4866-1807","authenticated-orcid":false,"given":"Henriette Pia","family":"Sennels","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital , 2400 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6374-761X","authenticated-orcid":false,"given":"Henrik L\u00f8vendahl","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , 2200 Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital \u2013 Hvidovre Hospital , 2650 Hvidovre ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4230-5753","authenticated-orcid":false,"given":"Nicolai Jacob","family":"Wewer Albrechtsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital , 2400 Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , 2200 Copenhagen ,","place":["Denmark"]},{"name":"Copenhagen Center for Translational Research, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital , 2400 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3861-8469","authenticated-orcid":false,"given":"Michael Martin","family":"Richter","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital , 2400 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"issue":"1","key":"2026081219565789100_dgag121-B1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ydbio.2004.01.046","article-title":"Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis","volume":"270","author":"Amthor","year":"2004","journal-title":"Dev Biol"},{"issue":"1","key":"2026081219565789100_dgag121-B2","doi-asserted-by":"crossref","first-page":"E157","DOI":"10.1152\/ajpendo.00193.2009","article-title":"Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin","volume":"297","author":"Gilson","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"10","key":"2026081219565789100_dgag121-B3","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/me.2010-0127","article-title":"Regulation of muscle mass by follistatin and activins","volume":"24","author":"Lee","year":"2010","journal-title":"Mol Endocrinol"},{"issue":"1","key":"2026081219565789100_dgag121-B4","doi-asserted-by":"crossref","first-page":"15153","DOI":"10.1038\/ncomms15153","article-title":"Activin A more prominently regulates muscle mass in primates than does GDF8","volume":"8","author":"Latres","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"2026081219565789100_dgag121-B5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/frne.1998.0169","article-title":"Follistatin: a multifunctional regulatory protein","volume":"19","author":"Phillips","year":"1998","journal-title":"Front Neuroendocrinol"},{"issue":"1-2","key":"2026081219565789100_dgag121-B6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mce.2004.02.010","article-title":"Autocrine\/paracrine regulation of pituitary function by activin, inhibin and follistatin","volume":"225","author":"Bilezikjian","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"23","key":"2026081219565789100_dgag121-B7","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1073\/pnas.84.23.8282","article-title":"Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone","volume":"84","author":"Ueno","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2026081219565789100_dgag121-B8","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1210\/jc.2004-0162","article-title":"Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay","volume":"89","author":"Schneyer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026081219565789100_dgag121-B9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1210\/en.2010-0868","article-title":"Exercise induces a marked increase in plasma follistatin: evidence that follistatin is a contraction-induced hepatokine","volume":"152","author":"Hansen","year":"2011","journal-title":"Endocrinology"},{"issue":"11","key":"2026081219565789100_dgag121-B10","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1210\/jc.2011-1665","article-title":"Energy deprivation alters in a leptin- and cortisol-independent manner circulating levels of activin A and follistatin but not myostatin in healthy males","volume":"96","author":"Vamvini","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026081219565789100_dgag121-B11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/dmrr.2415","article-title":"Plasma follistatin is elevated in patients with type 2 diabetes: relationship to hyperglycemia, hyperinsulinemia, and systemic low-grade inflammation","volume":"29","author":"Hansen","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"issue":"10","key":"2026081219565789100_dgag121-B12","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.metabol.2013.05.003","article-title":"Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers","volume":"62","author":"Teede","year":"2013","journal-title":"Metabolism"},{"issue":"9","key":"2026081219565789100_dgag121-B13","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/ajg.2009.318","article-title":"A complex role of activin A in non-alcoholic fatty liver disease","volume":"104","author":"Yndestad","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2026081219565789100_dgag121-B14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jc.2015-3668","article-title":"Circulating follistatin is liver-derived and regulated by the glucagon-to-insulin ratio","volume":"101","author":"Hansen","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026081219565789100_dgag121-B15","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.metabol.2016.07.002","article-title":"Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans","volume":"65","author":"Anastasilakis","year":"2016","journal-title":"Metabolism"},{"issue":"9","key":"2026081219565789100_dgag121-B16","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jgs.14927","article-title":"Treatment of sarcopenia with bimagrumab: results from a phase II, randomized, controlled, proof-of-concept study","volume":"65","author":"Rooks","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"2026081219565789100_dgag121-B17","doi-asserted-by":"crossref","first-page":"e2033457","DOI":"10.1001\/jamanetworkopen.2020.33457","article-title":"Effect of bimagrumab vs placebo on body fat mass among adults with type 2 diabetes and obesity: a phase 2 randomized clinical trial","volume":"4","author":"Heymsfield","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2026081219565789100_dgag121-B18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mus.21244","article-title":"Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease","volume":"39","author":"Rodino-Klapac","year":"2009","journal-title":"Muscle Nerve"},{"issue":"2","key":"2026081219565789100_dgag121-B19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/humrep\/deh607","article-title":"Diurnal changes in FSH-regulatory peptides and their relationship to gonadotrophins in pubertal girls","volume":"20","author":"Foster","year":"2005","journal-title":"Hum Reprod"},{"issue":"1","key":"2026081219565789100_dgag121-B20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-neuro-060909-153128","article-title":"Central and peripheral circadian clocks in mammals","volume":"35","author":"Mohawk","year":"2012","journal-title":"Annu Rev Neurosci"},{"key":"2026081219565789100_dgag121-B21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-319-27069-2_2","volume-title":"A Time for Metabolism and Hormones","author":"Takahashi","year":"2016"},{"issue":"3","key":"2026081219565789100_dgag121-B22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41366-020-00719-9","article-title":"The importance of 24-h metabolism in obesity-related metabolic disorders: opportunities for timed interventions","volume":"45","author":"Andriessen","year":"2021","journal-title":"Int J Obes"},{"issue":"1","key":"2026081219565789100_dgag121-B23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/07487304211064218","article-title":"Disturbance of the circadian system in shift work and its health impact","volume":"37","author":"Boivin","year":"2022","journal-title":"J Biol Rhythms"},{"issue":"8","key":"2026081219565789100_dgag121-B24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrn1177","article-title":"A clockwork web: circadian timing in brain and periphery, in health and disease","volume":"4","author":"Hastings","year":"2003","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2026081219565789100_dgag121-B25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/ejn.14255","article-title":"Circadian disruption: what do we actually mean?","volume":"51","author":"Vetter","year":"2020","journal-title":"Eur J Neurosci"},{"issue":"1","key":"2026081219565789100_dgag121-B26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12902-024-01566-9","article-title":"Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males","volume":"24","author":"Zilstorff","year":"2024","journal-title":"BMC Endocr Disord"},{"issue":"8","key":"2026081219565789100_dgag121-B27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3109\/00365513.2015.1080385","article-title":"Diurnal changes of biochemical metabolic markers in healthy young males - the Bispebjerg study of diurnal variations","volume":"75","author":"Sennels","year":"2015","journal-title":"Scand J Clin Lab Invest"},{"issue":"22","key":"2026081219565789100_dgag121-B28","doi-asserted-by":"crossref","first-page":"e70672","DOI":"10.14814\/phy2.70672","article-title":"Temporal variation in circulating GDF15 over 24h in healthy young males","volume":"13","author":"Zilstorff","year":"2025","journal-title":"Physiol Rep"},{"issue":"7","key":"2026081219565789100_dgag121-B29","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3109\/00365513.2011.602422","article-title":"Diurnal variation of hematology parameters in healthy young males: the Bispebjerg study of diurnal variations","volume":"71","author":"Sennels","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"2026081219565789100_dgag121-B30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-4682-11-16","article-title":"Cosinor-based rhythmometry","volume":"11","author":"Cornelissen","year":"2014","journal-title":"Theor Biol Med Model"},{"key":"2026081219565789100_dgag121-B31","doi-asserted-by":"crossref","unstructured":"Zilstorff DB, Sennels HP, J\u00f8rgensen HL, Wewer Albrechtsen NJ, Richter MM. 2026. Data from: Supplementary data for Circulating plasma follistatin follows a 24-hour rhythm in healthy young males. Zenodo. 10.5281\/zenodo.18807248.","DOI":"10.1210\/clinem\/dgag121"},{"key":"2026081219565789100_dgag121-B32","doi-asserted-by":"crossref","first-page":"170978","DOI":"10.1016\/j.peptides.2023.170978","article-title":"Postprandial secretion of follistatin after gastric bypass surgery and sleeve gastrectomy","volume":"163","author":"Richter","year":"2023","journal-title":"Peptides"},{"issue":"5","key":"2026081219565789100_dgag121-B33","doi-asserted-by":"crossref","first-page":"G753","DOI":"10.1152\/ajpgi.00396.2020","article-title":"Follistatin secretion is enhanced by protein, but not glucose or fat ingestion, in obese persons independently of previous gastric bypass surgery","volume":"320","author":"Bojsen-M\u00f8ller","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"2026081219565789100_dgag121-B34","doi-asserted-by":"crossref","first-page":"bvab121","DOI":"10.1210\/jendso\/bvab121","article-title":"The regulation of circulating hepatokines by fructose ingestion in humans","volume":"5","author":"Richter","year":"2021","journal-title":"J Endocr Soc"},{"issue":"3","key":"2026081219565789100_dgag121-B35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/dom.13572","article-title":"Follistatins in glucose regulation in healthy and obese individuals","volume":"21","author":"Perakakis","year":"2019","journal-title":"Diabetes Obes Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag121\/67422323\/dgag121.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/9\/e2154\/67422323\/dgag121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/9\/e2154\/67422323\/dgag121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:57:08Z","timestamp":1786579028000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/9\/e2154\/8529592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,3,19]]},"published-print":{"date-parts":[[2026,8,13]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag121","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,3,19]]}}}